Edition:
United Kingdom

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

19.84USD
20 Apr 2018
Change (% chg)

$-0.66 (-3.22%)
Prev Close
$20.50
Open
$20.30
Day's High
$20.30
Day's Low
$19.84
Volume
1,151
Avg. Vol
12,595
52-wk High
$51.90
52-wk Low
$17.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 0.02 -2.772
FY 2017 Dec '17 3.77 -0.166
Oct '17 0.02 -2.772
Jan '17 13.53 4.908
Oct 1.12 -0.301
FY 2016 Jul '16 0.31 -0.546
Apr '16 2.61 0.152
Jan '16 6.86 1.524
Oct 0.12 -6.005
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.34 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta -0.31 0.89 0.88
Price to Sales (TTM) 4.86 3.94 5.71
Price to Book (MRQ) 16.95 4.80 5.37
Price to Tangible Book (MRQ) 17.07 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 1.32 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) 0.00 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -99.30 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago 43.34 4.83 5.69
Sales - 5 Yr. Growth Rate -- 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,121.18 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago 148.03 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate -- 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 3.13 2.90 2.98
LT Debt to Equity (MRQ) 0.00 9.88 12.18
Total Debt to Equity (MRQ) 0.00 13.86 16.45
Interest Coverage (TTM) -57.11 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.44
Gross Margin - 5 Yr. Avg. -- 52.15 52.20
EBITD Margin (TTM) 39.02 -- --
EBITD - 5 Yr. Avg -411.24 18.57 10.96
Operating Margin (TTM) 38.98 14.36 4.73
Operating Margin - 5 Yr. Avg. -411.30 14.52 6.40
Pre-Tax Margin (TTM) 38.90 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -418.72 14.90 6.81
Net Profit Margin (TTM) 38.90 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -418.72 11.20 3.09
Effective Tax Rate (TTM) 0.00 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 938,079,949 846,830,978
Net Income/Employee (TTM) -- 110,368,367 99,616,195
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 2.44 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 95.09 11.40 10.95
Return on Assets - 5 Yr. Avg. -1,951.46 12.91 12.31
Return on Investment (TTM) 231.11 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.10
Return on Equity (TTM) 2,031.09 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % 538.55 -- --
EPS (TTM) % -5.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Opiant Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.88%
# of Holders: 18
Total Shares Held: 100,368
3 Mo. Net Change: 2,640
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.